Trials / Unknown
UnknownNCT02324400
Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Nephera Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study is intended to verify the safety and assess the performance of up to 3-days treatment protocol with the RenaSense System in ADHF patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RenaSense Stimulation | RenaSense Catheter, Electrical Stimulation of the Urinary Bladder Wall |
| DEVICE | RenaSense Sham Control | RenaSense Catheter,no delivery of stimulation |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-01-01
- First posted
- 2014-12-24
- Last updated
- 2014-12-24
Locations
3 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT02324400. Inclusion in this directory is not an endorsement.